A role of serum-based neuronal and glial markers as potential predictors for distinguishing severity and related outcomes in traumatic brain injury

Journal of Korean Neurosurgical Society

Volumn 58, Issue 2, 2015, Pages 93-100

  Lee, Jae Yoon ^a   Lee, Cheol Young ^a,b,c   Kim, Hong Rye ^a   Lee, Chang Hyun ^a   Kim, Hyun Woo ^a   Kim, Jong Hyun ^a  

^a Konyang University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Konyang University   (South Korea)

Author keywords

Biological markers; Brain injuries; Glial fibrillary acidic protein; S100 calcium binding protein beta subunit; Ubiquitin thiolesterase

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B; UBIQUITIN THIOLESTERASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HOSPITALIZATION; HUMAN; MALE; RECEIVER OPERATING CHARACTERISTIC; TRAUMATIC BRAIN INJURY;

EID: 84940737907     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2015.58.2.93     Document Type: Article

References (36)

1. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36: 959-969, 2000
2. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G: High serum S100B levels for trauma patients without head injuries. Neurosurgery 48: 1255-1258; discussion 1258-1260, 2001
3. Baker SP, O'Neill B, Haddon W Jr, Long WB: The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14: 187-196, 1974
4. Bell MJ, Kochanek PM, Heyes MP, Wisniewski SR, Sinz EH, Clark RS, et al.: Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med 27: 493-497, 1999
5. Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD: Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 24: 1793-1801, 2007
6. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, et al.: Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109: E31, 2002
7. Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, et al.: Protein S-100b serum levels in trauma-induced brain death. Neurology 60: 947-951, 2003
8. Eccles MP, Foy R, Sales A, Wensing M, Mittman B: Implementation Science six years on--our evolving scope and common reasons for rejection without review. Implement Sci 7: 71, 2012
9. Hamm CW, Katus HA: New biochemical markers for myocardial cell injury. Curr Opin Cardiol 10: 355-360, 1995
10. Hammond FM, Grattan KD, Sasser H, Corrigan JD, Bushnik T, Zafonte RD: Long-term recovery course after traumatic brain injury: a comparison of the functional independence measure and disability rating scale. J Head Trauma Rehabil 16: 318-329, 2001
11. Hans P, Born JD, Albert A: "Extrapolated" creatine kinase-BB isoenzyme activity in assessment of initial brain damage after severe head injury. J Neurosurg 66: 714-717, 1987
12. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA: Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med 358: 453-463, 2008
13. Jackson P, Thompson RJ: The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J Neurol Sci 49: 429-438, 1981
14. Kleiman NS, Lakkis N, Cannon CP, Murphy SA, DiBattiste PM, Demopoulos LA, et al.: Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 40: 1044-1050, 2002
15. Kruse A, Cesarini KG, Bach FW, Persson L: Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation. Acta Neurochir (Wien) 110: 106-109, 1991
16. Middeldorp J, Hol EM: GFAP in health and disease. Prog Neurobiol 93: 421-443, 2011
17. Mishra A, Srivastava C, Singh SK, Chandra A, Ojha BK: Choroid plexus carcinoma: case report and review of literature. J Pediatr Neurosci 7: 71-73, 2012
18. Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28: 1956-1960, 1997
19. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenström H: Measurement of glial fibrillary acidic protein in human blood: analyti cal method and preliminary clinical results. Clin Chem 45: 138-141, 1999
20. Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, et al.: Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery 70: 666-675, 2012
21. Morganti-Kossmann MC, Hans VH, Lenzlinger PM, Dubs R, Ludwig E, Trentz O, et al.: TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma 16: 617-628, 1999
22. Papa L, Lewis LM, Silvestri S, Falk JL, Giordano P, Brophy GM, et al.: Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg 72: 1335-1344, 2012
23. Park JE, Kim SH, Yoon SH, Cho KG, Kim SH: Risk Factors Predicting Unfavorable Neurological Outcome during the Early Period after Traumatic Brain Injury. J Korean Neurosurg Soc 45: 90-95, 2009
24. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H: GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 21: 1553-1561, 2004
25. Pickett W, Ardern C, Brison RJ: A population-based study of potential brain injuries requiring emergency care. CMAJ 165: 288-292, 2001
26. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V: Serum S-100B protein in severe head injury. Neurosurgery 45: 477-483, 1999
27. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ: Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10: 471-476, 1996
28. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT, et al.: Classification of traumatic brain injury for targeted therapies. J Neurotrauma 25: 719-738, 2008
29. Schäfer BW, Heizmann CW: The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 21: 134-140, 1996
30. Siman R, Toraskar N, Dang A, McNeil E, McGarvey M, Plaum J, et al.: A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma 26: 1867-1877, 2009
31. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E: S-100ao protein in blood and urine during open-heart surgery. Clin Chem 35: 1942-1944, 1989
32. van Geel WJ, de Reus HP, Nijzing H, Verbeek MM, Vos PE, Lamers KJ: Measurement of glial fibrillary acidic protein in blood: an analytical method. Clin Chim Acta 326: 151-154, 2002
33. Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T: Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 43: 267-270; discussion 270-271, 1995
34. Yoon KH, Han KS, Sung MM: Fabrication of a new type of organic-inorganic hybrid superlattice films combined with titanium oxide and polydiacetylene. Nanoscale Res Lett 7: 71, 2012
35. Zimmer DB, Cornwall EH, Landar A, Song W: The S100 protein family: history, function, and expression. Brain Res Bull 37: 417-429, 1995
36. Zoltewicz JS, Scharf D, Yang B, Chawla A, Newsom KJ, Fang L: Characterization of antibodies that detect human GFAP after traumatic brain injury. Biomark Insights 7: 71-79, 2012